Filagra DXT Plus – Comprehensive Oral Therapy for Erectile Dysfunction and Premature Ejaculation
Product Overview:
Filagra DXT Plus is a dual-action pharmaceutical solution developed to address erectile dysfunction (ED) and associated ejaculatory concerns across a wide range of underlying causes. Manufactured by Fortune Health Care, a trusted Indian pharmaceutical company known for its high-quality and cost-effective formulations, Filagra DXT Plus combines Sildenafil Citrate (100 mg) and Duloxetine (30 mg) to deliver enhanced sexual performance.
Therapeutic Profile:
This formulation functions as a modern, clinically effective alternative to Viagra®, offering comparable pharmacological efficacy at a more affordable price point—an important consideration for patients requiring ongoing ED treatment.
Sildenafil Citrate (100 mg): A PDE5 inhibitor that enhances penile blood flow, facilitating strong, sustained erections.
Duloxetine (30 mg): An SNRI that aids in delaying ejaculation and improving sexual stamina by modulating neurotransmitter levels.
Administration Guidelines:
Filagra DXT Plus is intended for oral use and should be taken approximately one hour prior to sexual activity, accompanied by a full glass of water. The onset of action typically occurs within 30 to 50 minutes, depending on individual metabolic response.
Key Advantages:
- Dual-action treatment for ED and premature ejaculation
- Cost-effective alternative to leading brand-name medications
- Manufactured under high-quality pharmaceutical standards
- Supports improved confidence and performance in sexual activity
Filagra DXT Plus is an ideal choice for men seeking reliable, accessible, and clinically supported treatment for sexual performance concerns, enabling a more fulfilling and confident intimate experience.
